News from novo nordisk A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 25, 2014, 13:48 ET

Demuestran datos recientes la eficacia y seguridad de la insulina degludec, como la nueva opción de tratamiento para niños y adolescentes con diabetes.

Durante la 50ª reunión anual de la Asociación Europea para el Estudio de la Diabetes (EASD por sus siglas en inglés), que se...

Sep 18, 2014, 09:00 ET

Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program

 Novo Nordisk announced today its support of the National Hemophilia Foundation's (NHF) new three-year initiative, Collaborating in Care, which...

Sep 18, 2014, 07:59 ET

Novo Nordisk Marks 90 Years of Innovating Diabetes Care

Denmark's Crown Prince Couple Help Celebrate Canadian, Danish Partnership, Marking Novo Nordisk's 30 Years in Canada MISSISSAUGA, ON, Sept. 18,...

Sep 15, 2014, 08:07 ET

Congress, MAGIC Call for Early Detection and Awareness of Children's Growth Patterns

 The MAGIC (Major Aspects of Growth In Children) Foundation®, a nonprofit organization that provides support services for the families of...

Sep 11, 2014, 20:49 ET

Saxenda® for the treatment of obesity receives positive 14-1 vote in favor of approval from FDA Advisory Committee

Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the Food and Drug Administration (FDA) has...

Sep 01, 2014, 11:04 ET

México se convierte en el primer país en lanzar Ryzodeg®

Novo Nordisk anunció hoy que en México es el primer país de todo el mundo en el que se ha lanzado Ryzodeg®, estando disponible...

Aug 28, 2014, 08:30 ET

New US study shows some minority groups with diabetes experience positive psychological outcomes but report high levels of diabetes distress

 Results from an analysis of US respondents from Novo Nordisk's Diabetes Attitudes, Wishes and Needs 2 (DAWN2™) study were published...

Aug 25, 2014, 09:00 ET

Novo Nordisk Kicks Off HeroPath™ Life Coach Program for Teens and Young Adults With Hemophilia

 Novo Nordisk announced the launch of the HeroPath™ Life Coach Program, an empowering, yearlong program that connects teens and young...

Jul 07, 2014, 13:32 ET

FDA Approves NovoSeven® RT for the Treatment of Glanzmann's Thrombasthenia (GT) With Refractoriness

 Novo Nordisk today announced the US Food and Drug Administration (FDA) has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant])...

Jun 25, 2014, 08:00 ET

Novo Nordisk and NBA Legend Dominique Wilkins Spotlight Full-Court Approach to Type 2 Diabetes Management

Novo Nordisk is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to...

Jun 21, 2014, 14:00 ET

Phase 3a Liraglutide 3 mg Trial Demonstrated Significant Weight Loss and Improved Cardiovascular Risk Factors in Adults With Obesity and Type 2 Diabetes Compared With Placebo

Today, new data from the phase 3a SCALE™ Diabetes trial were presented at the International Congress of Endocrinology (ICE) and the...

Jun 21, 2014, 14:00 ET

New Phase 3a Liraglutide 3 mg Data Showed Positive Impact on Cardiovascular Risk Markers and Fewer People Progressing to Pre-Diabetes Compared With Placebo in Adults With Obesity

Today, new data from the phase 3a SCALE™ Obesity and Pre-diabetes trial were presented at the International Congress of Endocrinology (ICE)...

Jun 19, 2014, 09:00 ET

Novo Nordisk Announces U.S. Launch of New Insulin Device Levemir® FlexTouch®

Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir®...

Jun 14, 2014, 13:00 ET

New Phase 3 Study Shows Efficacy and Safety of Victoza® (Liraglutide [rDNA origin] Injection) for the Treatment of Type 2 Diabetes in Adults with Moderate Renal Impairment

Data from a new phase 3 study demonstrated that once-daily Victoza® (liraglutide [rDNA origin] injection) provided greater glycaemic control...

Jun 14, 2014, 11:45 ET

New One-year Data of IDegLira Shows Glucose-lowering Effect was Maintained for People with Type 2 Diabetes

New Phase 3a findings show IDegLira, the investigational once-daily single injection combination of insulin degludec and liraglutide, for the...

Jun 14, 2014, 11:30 ET

Phase 3a Data Showed Liraglutide 3 mg Demonstrated Significantly Greater Weight Loss Compared to Placebo in Adults With Obesity and Type 2 Diabetes

Today, primary results from SCALE™ Diabetes, a phase 3a clinical trial of liraglutide 3 mg, an investigational once-daily glucagon-like...

Jun 06, 2014, 09:00 ET

Novo Nordisk Honored with 2014 New Good Neighbor Award by New Jersey Business & Industry Association

Novo Nordisk, a global health care company with more than 90 years of innovation and leadership in diabetes care, will be presented today with a...

May 16, 2014, 06:00 ET

Phase 3a data from largest trial with liraglutide 3 mg demonstrated significantly greater weight loss versus placebo for adults with obesity

 Results from the SCALE™ Obesity and Pre-diabetes phase 3a trial will be presented on May 16, 2014, for the first time at the 23rd Annual...

May 12, 2014, 07:39 ET

NovoEight® reduce las hemorragias en personas con hemofilia A a largo plazo

Hoy Novo Nordisk ha anunciado nuevos datos provisionales de la fase 3 de su ensayo clínico guardian™2 para su producto NovoEight®...